261 related articles for article (PubMed ID: 2944857)
1. Family study in familial hypercholesterolemia with a receptor-negative homozygous 9-year-old boy.
Clemens P; Beisiegel U; Steinhagen-Thiessen E
Helv Paediatr Acta; 1986 Aug; 41(3):173-82. PubMed ID: 2944857
[TBL] [Abstract][Full Text] [Related]
2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
3. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
Feussner G; Dobmeyer J; Nissen H; Hansen TS
Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
[TBL] [Abstract][Full Text] [Related]
4. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
Brugger D; Schuster H; Zöllner N
Eur J Med Res; 1996 May; 1(8):383-6. PubMed ID: 9360938
[TBL] [Abstract][Full Text] [Related]
5. Relationship between apolipoprotein(a) phenotype, lipoprotein(a) concentration in plasma, and low density lipoprotein receptor function in a large kindred with familial hypercholesterolemia due to the pro664----leu mutation in the LDL receptor gene.
Soutar AK; McCarthy SN; Seed M; Knight BL
J Clin Invest; 1991 Aug; 88(2):483-92. PubMed ID: 1830890
[TBL] [Abstract][Full Text] [Related]
6. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
[TBL] [Abstract][Full Text] [Related]
7. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
[TBL] [Abstract][Full Text] [Related]
8. Concentrations of the atherogenic Lp(a) are elevated in FH.
Lingenhel A; Kraft HG; Kotze M; Peeters AV; Kronenberg F; Kruse R; Utermann G
Eur J Hum Genet; 1998 Jan; 6(1):50-60. PubMed ID: 9781014
[TBL] [Abstract][Full Text] [Related]
9. A xanthomatosis-susceptibility gene may exist in a Syrian family with familial hypercholesterolemia.
Vergopoulos A; Bajari T; Jouma M; Knoblauch H; Aydin A; Bähring S; Mueller-Myhsok B; Dresel A; Joubran R; Luft FC; Schuster H
Eur J Hum Genet; 1997; 5(5):315-23. PubMed ID: 9412789
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.
März W; Baumstark MW; Scharnagl H; Ruzicka V; Buxbaum S; Herwig J; Pohl T; Russ A; Schaaf L; Berg A
J Clin Invest; 1993 Dec; 92(6):2922-33. PubMed ID: 8254047
[TBL] [Abstract][Full Text] [Related]
11. [Three-year-old boy--a homozygote for familiar hypercholesterolemia].
Dumić M; Uroic AS; Francetić I; Puretić Z; Matisić D; Kes P; Mikecin M; Reiner Z
Lijec Vjesn; 2007 May; 129(5):130-3. PubMed ID: 17695192
[TBL] [Abstract][Full Text] [Related]
12. Familial defective apolipoprotein B-100.
Hansen PS
Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
[TBL] [Abstract][Full Text] [Related]
13. Moderate phenotypic expression of familial hypercholesterolemia in Tunisia.
Jelassi A; Slimani A; Jguirim I; Najah M; Abid A; Boughamoura L; Mzid J; Fkih M; Maatouk F; Rouis M; Varret M; Slimane MN
Clin Chim Acta; 2010 May; 411(9-10):735-8. PubMed ID: 20144596
[TBL] [Abstract][Full Text] [Related]
14. Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation.
Civeira F; Castillo S; Alonso R; Meriño-Ibarra E; Cenarro A; Artied M; Martín-Fuentes P; Ros E; Pocoví M; Mata P;
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1960-5. PubMed ID: 16020744
[TBL] [Abstract][Full Text] [Related]
15. A double mutant [N543H+2393del9] allele in the LDL receptor gene in familial hypercholesterolemia: effect on plasma cholesterol levels and cardiovascular disease.
Castillo S; Reyes G; Tejedor D; Mozas P; Suarez Y; Lasuncion MA; Cenarro A; Civeira F; Alonso R; Mata P; Pocovi M;
Hum Mutat; 2002 Dec; 20(6):477. PubMed ID: 12442279
[TBL] [Abstract][Full Text] [Related]
16. HDL cholesterol levels in patients with molecularly defined familial hypercholesterolemia.
Miltiadous G; Cariolou MA; Elisaf M
Ann Clin Lab Sci; 2002; 32(1):50-4. PubMed ID: 11848618
[TBL] [Abstract][Full Text] [Related]
17. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
[TBL] [Abstract][Full Text] [Related]
18. The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.
Rader DJ; Mann WA; Cain W; Kraft HG; Usher D; Zech LA; Hoeg JM; Davignon J; Lupien P; Grossman M
J Clin Invest; 1995 Mar; 95(3):1403-8. PubMed ID: 7883987
[TBL] [Abstract][Full Text] [Related]
19. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations.
Dedoussis GV; Skoumas J; Pitsavos C; Choumerianou DM; Genschel J; Schmidt H; Stefanadis C
Eur J Clin Invest; 2004 Jun; 34(6):402-9. PubMed ID: 15200491
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of a newly discovered LDL receptor mutation (exon 10, GAC>AAC, D271N, "FH Graz-1") in familial hypercholesterolemia-- a familystudy].
de Campo A; Toplak H; Wascher TC; Schallmoser K; Friehs A; Schmidt H; Kostner GM
Acta Med Austriaca; 1999; 26(1):20-5. PubMed ID: 10230472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]